Balance Sheet Veeva Systems Inc.

Equities

VEEV

US9224751084

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 16:04:29 2026-04-17 EDT			5-day change	1st Jan Change
167.95 ^USD	+0.16%		+10.91%	-24.76%

04-10	Veeva Systems Shares Fall After Citigroup Downgrade	MT
04-10	Citigroup Downgrades Veeva Systems to Neutral From Buy, Adjusts Price Target to $176 From $291	MT

785784328e7c804.DpRBYy_VcyPmx1dJTVmmkQAr80AFDf_K8V_6J4DRJPI.Rct4BkyYBHq5oWJ6BDXly0Zbhwt0WpqSsxagTuSwUbtL7DIFGaxHTq2TNA

Published financial data: VEEVA SYSTEMS INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: January	2022	2023	2024	2025	2026
Revenues	1.85B	2.16B	2.36B	2.75B	3.2B
Total Revenues	1.85B	2.16B	2.36B	2.75B	3.2B
Cost of Goods Sold, Total	504M	609M	677M	700M	782M
Gross Profit	1.35B	1.55B	1.69B	2.05B	2.41B
Selling General & Admin Expenses, Total	460M	566M	628M	657M	699M
R&D Expenses	382M	520M	629M	693M	767M
Other Operating Expenses, Total	842M	1.09B	1.26B	1.35B	1.47B
Operating Income	505M	459M	429M	696M	947M
Interest And Investment Income	14.73M	45.86M	134M	208M	267M
Net Interest Expenses	14.73M	45.86M	134M	208M	267M
Currency Exchange Gains (Loss)	-714K	591K	124K	-3.27M	1.54M
Other Non Operating Income (Expenses)	-	572K	-	611K	934K
EBT, Excl. Unusual Items	520M	506M	563M	902M	1.22B
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-7.2M	2.98M	24.82M	22.62M	8.45M
Legal Settlements	-	-	-	-5M	-30.63M
EBT, Incl. Unusual Items	512M	509M	588M	919M	1.19B
Income Tax Expense	84.92M	21.39M	62.32M	205M	286M
Earnings From Continuing Operations	427M	488M	526M	714M	909M
Net Income to Company	427M	488M	526M	714M	909M
Net Income - (IS)	427M	488M	526M	714M	909M
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	427M	488M	526M	714M	909M
Net Income to Common Excl. Extra Items	427M	488M	526M	714M	909M
Per Share Items
Net EPS - Basic	2.79	3.14	3.27	4.41	5.55
Basic EPS - Continuing Operations	2.79	3.14	3.27	4.41	5.55
Basic Weighted Average Shares Outstanding	153M	155M	161M	162M	164M
Net EPS - Diluted	2.63	3	3.22	4.32	5.44
Diluted EPS - Continuing Operations	2.63	3	3.22	4.32	5.44
Diluted Weighted Average Shares Outstanding	162M	162M	163M	165M	167M
Normalized Basic EPS	2.12	2.04	2.19	3.48	4.65
Normalized Diluted EPS	2	1.95	2.15	3.41	4.55
Supplemental Items
EBITDA	533M	488M	462M	736M	985M
EBITA	524M	478M	448M	715M	961M
EBIT	505M	459M	429M	696M	947M
EBITDAR	547M	504M	478M	750M	1B
Total Revenues (As Reported)	1.85B	2.16B	2.36B	2.75B	3.2B
Effective Tax Rate - (Ratio)	16.58	4.2	10.6	22.32	23.91
Current Domestic Taxes	66.01M	140M	156M	307M	205M
Current Foreign Taxes	7.84M	8.51M	12.16M	10.9M	15.87M
Total Current Taxes	73.84M	149M	168M	318M	221M
Deferred Domestic Taxes	2.82M	-120M	-103M	-109M	68.64M
Deferred Foreign Taxes	8.26M	-7.82M	-1.98M	-3.67M	-3.55M
Total Deferred Taxes	11.08M	-128M	-105M	-112M	65.09M
Normalized Net Income	325M	316M	352M	564M	760M
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Selling and Marketing Expenses	288M	349M	381M	397M	429M
General and Administrative Expenses	172M	218M	247M	261M	270M
Research And Development Expense From Footnotes	382M	520M	629M	693M	767M
Net Rental Expense, Total	14M	16M	16M	14M	17M
Stock-Based Comp., COGS (Total)	41.09M	56.6M	59.72M	57.97M	64.72M
Stock-Based Comp., R&D Exp. (Total)	83.84M	142M	173M	186M	205M
Stock-Based Comp., S&M Exp. (Total)	56.83M	87.51M	90.86M	90.18M	97.36M
Stock-Based Comp., G&A Exp. (Total)	52.88M	66.23M	70.27M	103M	106M
Total Stock-Based Compensation	235M	352M	394M	437M	473M

Fiscal Period: January	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	1.14B	886M	703M	1.12B	1.42B
Short Term Investments	1.24B	2.22B	3.32B	4.03B	5.14B
Total Cash And Short Term Investments	2.38B	3.1B	4.03B	5.15B	6.56B
Accounts Receivable, Total	694M	785M	889M	1.06B	1.31B
Total Receivables	694M	785M	889M	1.06B	1.31B
Prepaid Expenses	35.46M	81.46M	86.92M	101M	126M
Other Current Assets, Total	1.22M	-	-	-	-
Total Current Assets	3.11B	3.97B	5B	6.31B	8B
Gross Property Plant And Equipment	134M	137M	141M	151M	180M
Accumulated Depreciation	-30.27M	-32.12M	-36.76M	-31.45M	-33.72M
Net Property Plant And Equipment	104M	105M	104M	120M	146M
Goodwill	440M	440M	440M	440M	440M
Other Intangibles, Total	102M	82.48M	63.02M	44.46M	30.31M
Deferred Tax Assets Long-Term	5.1M	137M	233M	344M	273M
Deferred Charges Long-Term	33.11M	31.82M	23.92M	26.38M	29.96M
Other Long-Term Assets, Total	25.13M	38.96M	43.3M	56.54M	62.26M
Total Assets	3.82B	4.8B	5.91B	7.34B	8.98B
Liabilities
Accounts Payable, Total	20.35M	41.68M	31.51M	30.45M	37.64M
Accrued Expenses, Total	69.94M	79.59M	76.41M	74.99M	91.74M
Current Portion of Leases	10.98M	11.31M	9.33M	9.97M	12.15M
Current Income Taxes Payable	7.76M	4.95M	11.86M	9.02M	6.7M
Unearned Revenue Current, Total	732M	869M	1.05B	1.27B	1.49B
Total Current Liabilities	841M	1.01B	1.18B	1.4B	1.64B
Long-Term Leases	43.61M	49.67M	46.44M	65.81M	83.71M
Deferred Tax Liability Non Current	2.22M	1.49M	2.05M	587K	558K
Other Non Current Liabilities	18.23M	30.08M	38.72M	42.59M	43.27M
Total Liabilities	905M	1.09B	1.27B	1.51B	1.76B
Common Stock, Total	2K	2K	2K	2K	2K
Additional Paid In Capital	1.2B	1.53B	1.92B	2.39B	2.84B
Retained Earnings	1.73B	2.21B	2.74B	3.45B	4.36B
Comprehensive Income and Other	-11.96M	-31.13M	-10.64M	-8.42M	8.16M
Total Common Equity	2.91B	3.72B	4.64B	5.83B	7.21B
Total Equity	2.91B	3.72B	4.64B	5.83B	7.21B
Total Liabilities And Equity	3.82B	4.8B	5.91B	7.34B	8.98B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	154M	160M	161M	163M	163M
ECS Total Common Shares Outstanding	154M	158M	161M	163M	164M
Book Value / Share	18.88	23.48	28.8	35.87	44.05
Tangible Book Value	2.37B	3.19B	4.14B	5.35B	6.74B
Tangible Book Value Per Share	15.37	20.18	25.68	32.89	41.18
Total Debt	54.59M	60.98M	55.78M	75.78M	95.86M
Net Debt	-2.32B	-3.04B	-3.97B	-5.07B	-6.46B
Debt Equivalent Oper. Leases	112M	128M	128M	112M	136M
Account Code - Inventory Valuation	3	3	3	3	3
Land - (BS)	3.04M	3.04M	3.04M	3.04M	3.04M
Buildings, Total	20.98M	20.98M	20.98M	20.98M	20.98M
Machinery, Total	18.62M	16.23M	18.05M	7.77M	10.35M
Full Time Employees	5.48K	6.74K	7.17K	7.29K	7.93K
Accumulated Allowance for Doubtful Accounts (Supple)	473K	469K	520K	57K	256K

Fiscal Period: January	2022	2023	2024	2025	2026
Net Income	427M	488M	526M	714M	909M
Depreciation & Amortization - CF	8.45M	10.12M	13.63M	20.38M	23.97M
Amortization of Goodwill and Intangible Assets - (CF)	19M	19M	19M	19M	14M
Depreciation & Amortization, Total	27.45M	29.12M	32.63M	39.38M	37.97M
Amortization of Deferred Charges, Total - (CF)	26.05M	22.1M	18.18M	15.53M	16.42M
(Gain) Loss on Sale of Investments - (CF)	6.26M	-3.62M	-26.52M	-24.44M	-9.69M
Stock-Based Compensation (CF)	235M	352M	394M	437M	473M
Provision and Write-off of Bad Debts	272K	256K	693K	-	-
Other Operating Activities, Total	21.74M	-114M	-93.9M	-99.52M	80.85M
Change In Accounts Receivable	-83.08M	-91.08M	-104M	-169M	-255M
Change In Accounts Payable	-3M	21.43M	-10.23M	-1.96M	6.08M
Change in Unearned Revenues	116M	140M	188M	228M	213M
Change In Income Taxes	5.28M	-2.82M	6.92M	-2.84M	-2.33M
Change in Other Net Operating Assets	-14.68M	-60.66M	-20.03M	-46.45M	-54.2M
Cash from Operations	764M	780M	911M	1.09B	1.42B
Capital Expenditure	-14.21M	-13.51M	-26.2M	-20.52M	-29.13M
Cash Acquisitions	-7.78M	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-324M	-994M	-1.05B	-680M	-1.08B
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-346M	-1.01B	-1.08B	-700M	-1.1B
Long-Term Debt Repaid, Total	-384K	-	-	-	-
Total Debt Repaid	-384K	-	-	-	-
Issuance of Common Stock	51.54M	43.65M	62.69M	106M	254M
Repurchase of Common Stock	-55.29M	-63.03M	-78.88M	-79.42M	-263M
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	-4.14M	-19.38M	-16.19M	26.12M	-9.33M
Foreign Exchange Rate Adjustments	-4.66M	-4.99M	-1.78M	-1.74M	919K
Net Change in Cash	410M	-252M	-183M	414M	302M
Supplemental Items
Cash Income Tax Paid (Refund)	58.63M	168M	134M	322M	230M
Levered Free Cash Flow	632M	707M	752M	943M	1.05B
Unlevered Free Cash Flow	632M	707M	752M	943M	1.05B
Change In Net Working Capital	-41.69M	-30.09M	-65.28M	-35.77M	41.77M
Net Debt Issued / Repaid	-384K	-	-	-	-

Fiscal Period: January	2022	2023	2024	2025	2026
Profitability
Return on Assets	9.21	6.66	5.01	6.57	7.25
Return on Total Capital	11.93	8.51	6.33	8.21	8.96
Return On Equity %	16.51	14.72	12.58	13.63	13.93
Return on Common Equity	16.51	14.72	12.58	13.63	13.93
Margin Analysis
Gross Profit Margin %	72.79	71.72	71.35	74.53	75.53
SG&A Margin	24.83	26.28	26.57	23.94	21.87
EBITDA Margin %	28.8	22.65	19.54	26.79	30.83
EBITA Margin %	28.34	22.18	18.97	26.05	30.08
EBIT Margin %	27.31	21.3	18.16	25.36	29.64
Income From Continuing Operations Margin %	23.09	22.63	22.24	26	28.44
Net Income Margin %	23.09	22.63	22.24	26	28.44
Net Avail. For Common Margin %	23.09	22.63	22.24	26	28.44
Normalized Net Income Margin	17.54	14.68	14.89	20.52	23.8
Levered Free Cash Flow Margin	34.12	32.79	31.81	34.33	32.8
Unlevered Free Cash Flow Margin	34.12	32.79	31.81	34.33	32.8
Asset Turnover
Asset Turnover	0.54	0.5	0.44	0.41	0.39
Fixed Assets Turnover	17.24	20.59	22.59	24.53	24.06
Receivables Turnover (Average Receivables)	2.83	2.91	2.82	2.82	2.7
Short Term Liquidity
Current Ratio	3.7	3.94	4.24	4.51	4.89
Quick Ratio	3.65	3.86	4.17	4.44	4.81
Operating Cash Flow to Current Liabilities	0.91	0.78	0.77	0.78	0.86
Days Sales Outstanding (Average Receivables)	128.78	125.3	129.23	129.63	135.22
Average Days Payable Outstanding	15.8	18.57	19.72	16.21	15.89
Long Term Solvency
Total Debt/Equity	1.87	1.64	1.2	1.3	1.33
Total Debt / Total Capital	1.84	1.61	1.19	1.28	1.31
LT Debt/Equity	1.5	1.34	1	1.13	1.16
Long-Term Debt / Total Capital	1.47	1.31	0.99	1.11	1.14
Total Liabilities / Total Assets	23.71	22.65	21.42	20.54	19.65
Total Debt / EBITDA	0.1	0.12	0.12	0.1	0.1
Net Debt / EBITDA	-4.24	-6.03	-8.31	-6.77	-6.45
Total Debt / (EBITDA - Capex)	0.1	0.12	0.12	0.1	0.1
Net Debt / (EBITDA - Capex)	-4.36	-6.2	-8.79	-6.96	-6.65
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	26.33	16.44	9.68	16.2	16.34
Gross Profit, 1 Yr. Growth %	27.55	14.74	9.1	21.38	17.9
EBITDA, 1 Yr. Growth %	30.86	-8.39	-5.38	59.28	33.86
EBITA, 1 Yr. Growth %	31.85	-8.85	-6.22	59.58	34.32
EBIT, 1 Yr. Growth %	33.8	-9.18	-6.48	62.21	35.98
Earnings From Cont. Operations, 1 Yr. Growth %	12.47	14.11	7.79	35.84	27.27
Net Income, 1 Yr. Growth %	12.47	14.11	7.79	35.84	27.27
Normalized Net Income, 1 Yr. Growth %	30.83	-2.58	11.28	60.11	34.92
Diluted EPS Before Extra, 1 Yr. Growth %	11.44	14.07	7.33	34.16	25.93
Accounts Receivable, 1 Yr. Growth %	13.54	13.08	13.16	18.97	23.95
Net Property, Plant and Equip., 1 Yr. Growth %	-5.82	0.98	-0.97	15.02	21.8
Total Assets, 1 Yr. Growth %	25.29	25.88	23.03	24.17	22.34
Tangible Book Value, 1 Yr. Growth %	38.13	34.77	29.68	29.12	26.11
Common Equity, 1 Yr. Growth %	28.47	27.63	24.99	25.57	23.7
Cash From Operations, 1 Yr. Growth %	38.68	2.09	16.77	19.61	29.83
Capital Expenditures, 1 Yr. Growth %	63.7	-4.94	93.87	-21.67	41.97
Levered Free Cash Flow, 1 Yr. Growth %	49.37	11.89	6.41	25.38	11.17
Unlevered Free Cash Flow, 1 Yr. Growth %	49.37	11.89	6.41	25.38	11.17
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	29.47	21.28	13.01	12.89	16.27
Gross Profit, 2 Yr. CAGR %	29.71	20.97	11.89	15.08	19.63
EBITDA, 2 Yr. CAGR %	31.95	9.49	-6.9	22.77	46.02
EBITA, 2 Yr. CAGR %	33.07	9.63	-7.55	22.33	46.41
EBIT, 2 Yr. CAGR %	32.9	10.24	-7.84	23.17	48.52
Earnings From Cont. Operations, 2 Yr. CAGR %	19.14	13.29	10.91	21.01	31.49
Net Income, 2 Yr. CAGR %	19.14	13.29	10.91	21.01	31.49
Normalized Net Income, 2 Yr. CAGR %	29.31	12.9	4.12	33.48	46.98
Diluted EPS Before Extra, 2 Yr. CAGR %	17.65	12.75	10.65	20	29.98
Accounts Receivable, 2 Yr. CAGR %	28.2	13.31	13.12	16.03	21.44
Net Property, Plant and Equip., 2 Yr. CAGR %	0.12	-2.48	-0	6.73	18.36
Total Assets, 2 Yr. CAGR %	29.61	25.59	24.45	23.6	23.25
Tangible Book Value, 2 Yr. CAGR %	47.28	36.44	32.2	29.4	27.61
Common Equity, 2 Yr. CAGR %	32.22	28.05	26.3	25.28	24.63
Cash From Operations, 2 Yr. CAGR %	32.21	18.99	9.18	18.18	24.62
Capital Expenditures, 2 Yr. CAGR %	81.37	24.75	35.76	23.23	5.45
Levered Free Cash Flow, 2 Yr. CAGR %	30.67	29.28	9.12	15.51	18.06
Unlevered Free Cash Flow, 2 Yr. CAGR %	30.67	29.28	9.12	15.51	18.06
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	29	24.97	17.29	14.06	14.03
Gross Profit, 3 Yr. CAGR %	29.73	24.51	16.88	14.97	16.01
EBITDA, 3 Yr. CAGR %	31.02	16.84	4.29	11.35	26.36
EBITA, 3 Yr. CAGR %	31.65	17.3	4.07	10.9	26.2
EBIT, 3 Yr. CAGR %	31.39	17.06	4.36	11.27	27.3
Earnings From Cont. Operations, 3 Yr. CAGR %	22.97	17.44	11.43	18.66	23.06
Net Income, 3 Yr. CAGR %	22.97	17.44	11.43	18.66	23.06
Normalized Net Income, 3 Yr. CAGR %	30.06	17.66	12.36	20.18	33.96
Diluted EPS Before Extra, 3 Yr. CAGR %	21.4	16.45	10.91	17.99	21.94
Accounts Receivable, 3 Yr. CAGR %	29.25	22.95	13.26	15.04	18.61
Net Property, Plant and Equip., 3 Yr. CAGR %	23.74	0.41	-1.98	4.77	11.53
Total Assets, 3 Yr. CAGR %	32.15	28.36	24.73	24.36	23.18
Tangible Book Value, 3 Yr. CAGR %	28.48	42.99	34.15	31.17	28.3
Common Equity, 3 Yr. CAGR %	32.99	30.67	27.02	26.06	24.75
Cash From Operations, 3 Yr. CAGR %	34.98	21.29	18.24	12.55	21.94
Capital Expenditures, 3 Yr. CAGR %	13.12	46.23	44.5	13.02	29.18
Levered Free Cash Flow, 3 Yr. CAGR %	37.98	24.08	21.16	14.29	14.04
Unlevered Free Cash Flow, 3 Yr. CAGR %	37.98	24.08	21.16	14.29	14.04
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	27.44	25.56	22.35	19.99	16.88
Gross Profit, 5 Yr. CAGR %	29.02	26.4	22.28	20.65	17.97
EBITDA, 5 Yr. CAGR %	31.7	23.17	14.29	19.18	19.32
EBITA, 5 Yr. CAGR %	32.41	23.6	14.29	19.29	19.29
EBIT, 5 Yr. CAGR %	33.17	23.79	14.01	19.46	20.18
Earnings From Cont. Operations, 5 Yr. CAGR %	40.68	26.4	18	18.85	19.06
Net Income, 5 Yr. CAGR %	40.68	26.4	18	18.85	19.06
Normalized Net Income, 5 Yr. CAGR %	33.15	24.75	18.99	23.75	25.1
Diluted EPS Before Extra, 5 Yr. CAGR %	37.76	25.08	16.98	17.85	18.18
Accounts Receivable, 5 Yr. CAGR %	30.59	26.96	22.54	20.13	16.46
Net Property, Plant and Equip., 5 Yr. CAGR %	15.85	15	13.63	2.89	5.7
Total Assets, 5 Yr. CAGR %	32.99	31.32	29.01	26.43	24.14
Tangible Book Value, 5 Yr. CAGR %	35.57	32.61	29.96	37.39	31.49
Common Equity, 5 Yr. CAGR %	34.86	32.61	30.28	28.49	26.06
Cash From Operations, 5 Yr. CAGR %	39.63	27.3	24	20.04	20.75
Capital Expenditures, 5 Yr. CAGR %	15.47	7	21.68	36.56	27.39
Levered Free Cash Flow, 5 Yr. CAGR %	31.76	32.32	25.62	20.58	19.91
Unlevered Free Cash Flow, 5 Yr. CAGR %	31.76	32.32	25.62	20.58	19.91